Apelin Is a Prototype of Novel Drugs for the Treatment of Acute Myocardial Infarction and Adverse Myocardial Remodeling

• Päätekijät: Sergey V. Popov (Tekijä), Leonid N. Maslov (Tekijä), Alexandr V. Mukhomedzyanov (Tekijä), Boris K. Kurbatov (Tekijä), Alexandr S. Gorbunov (Tekijä), Michail Kilin (Tekijä), Viacheslav N. Azev (Tekijä), Maria S. Khlestkina (Tekijä), Galina Z. Sufianova (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: MDPI AG, 2023-03-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

In-hospital mortality in patients with ST-segment elevation myocardial infarction (STEMI) is 5-6%. Consequently, it is necessary to develop fundamentally novel drugs capable of reducing mortality in patients with acute myocardial infarction. Apelins could be the prototype for such drugs. Chronic adm...